
Experts discuss an overview of the STARTER-NET study, emphasizing its goals, key outcomes, and potential impact on clinical practice.

Experts discuss an overview of the STARTER-NET study, emphasizing its goals, key outcomes, and potential impact on clinical practice.

Experts discuss an overview of the ALASCCA study, highlighting its objectives, results, and clinical implications.

Experts discuss the CheckMate 8HW study, focusing on its design, key findings, and impact on treatment strategies.

Experts discuss an overview of the BREAKWATER study, highlighting its key objectives, findings, and implications.

Alok Khorana, MD, discusses the long-term impacts of tinzaparin versus warfarin, as well as clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients, in the CATCH study.

Published: September 4th 2015 | Updated: